Emmanuel Rio

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne et al. · The Lancet Oncology · 2021 · 1.3K citations

Medicine, Oncology, Surgery +17

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial.

Thierry Conroy, Najib Lamfichekh, Pierre-Luc Etienne et al. · Journal of Clinical Oncology · 2020 · 177 citations

Medicine, Oncology, Surgery +17

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.

Thierry Conroy, Pierre-Luc Etienne, Emmanuel Rio et al. · Journal of Clinical Oncology · 2023 · 109 citations

Medicine, Oncology, Surgery +17

Interstitial brachytherapy of periorificial skin carcinomas of the face: A retrospective study of 97 cases

Emmanuel Rio, É. Bardet, Christophe Ferron et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 78 citations

Medicine, Dermatology, Oncology +11

Efficacy of cetuximab in the treatment of squamous cell carcinoma

Sophie Preneau, Emmanuel Rio, A. Brocard et al. · Journal of Dermatological Treatment · 2012 · 72 citations

Medicine, Oncology, Pharmacology +14